Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects
To access this article, please choose from the options below
PII: S0969-8051(07)00036-4
doi:10.1016/j.nucmedbio.2007.01.009
© 2007 Elsevier Inc. All rights reserved.
